Roquefort Therapeutics (LSE:ROQ) PEG Ratio : N/A (As of Dec. 13, 2024)

Roquefort Therapeutics PEG Ratio Chart

Competitive Comparison of Roquefort Therapeutics's PEG Ratio

For the Biotechnology subindustry, Roquefort Therapeutics's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roquefort Therapeutics's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roquefort Therapeutics's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Roquefort Therapeutics's PEG Ratio falls into.

Roquefort Therapeutics PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Roquefort Therapeutics's PEG Ratio for today is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Roquefort Therapeutics  (LSE:ROQ) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Roquefort Therapeutics PEG Ratio Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics Business Description